July 4, 2020

Volume X, Number 186

Eric K. Steffe

Mr. Steffe is a director in the Biotechnology/Chemical Group where he counsels domestic and foreign clients in various matters involving biotechnology patent law. Mr. Steffe leads teams who create and manage complicated patent portfolios protecting pipeline and FDA-approved products for companies in the areas of immunology, antisense, protein therapy, personalized medicine and diagnostics, therapeutic antibodies, small molecules and vaccines. His also has significant expertise representing clients involved in contested case proceedings before the USPTO, including ex parte and inter partes patent reexaminations and interferences. 

Articles in the National Law Review database by Eric K. Steffe

LATEST LEGAL NEWS & ANALYSIS

TRENDING LEGAL ANALYSIS

Upcoming Legal Education Events

Tuesday, July 7, 2020
Wednesday, July 8, 2020
Wednesday, July 15, 2020
Wednesday, July 22, 2020